. HEDGES hG-CSF cDNA injection elicits the production of endogenous mouse anti-hG-CSF antibodies. Fig. S2 . Intravenous HEDGES injection of the human TP53 cDNA is expressed predominantly in mouse VECs. Fig. S3 . Intravenous injection of HEDGES vector DNA does not detectably integrate into genomic DNA of injected mice. Fig. S4 . HEDGES treatment with a β-GAL reporter-containing plasmid results in expression of reporter in CD31 + CD45lung cells in mice. Fig. S5 . Development of mouse anti-rituximab antibodies suppresses rituximab levels in HEDGES-treated mice. Table S1 . HEDGES expression plasmids. Fig. S1 . HEDGES hG-CSF cDNA injection elicits the production of endogenous mouse anti-hG-CSF antibodies. On day 0, groups of 3 CD1 mice were IV injected with Lactated Ringer's or with 1umol each of DOTAP liposomes and DMPC liposomes each incorporating 2.5% Dexamethasone 21-Palmitate, followed by 75ug of an hG-CSF cDNA expression vector. Mice were bled on day 1 and at weekly or bi-weekly intervals thereafter and analyzed for the presence of mouse anti-hG-CSF antibodies by ELISA. 
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